5-Chloro-3-[1-quinolin-2-yl-meth-(E)-ylidene]-1,3-dihydro-indol-2-one | 902758-57-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 5-Chloro-3-[1-quinolin-2-yl-meth-(E)-ylidene]-1,3-dihydro-indol-2-one
• 英文别名: (3E)-5-chloro-3-(quinolin-2-ylmethylidene)-1H-indol-2-one
• CAS: 902758-57-0
• 化学式: C₁₈H₁₁ClN₂O
• 分子量: 306.751
• InChiKey: LSUKYSMSWGNIMS-XNTDXEJSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  22
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-Chloro-3-[1-quinolin-2-yl-meth-(E)-ylidene]-1,3-dihydro-indol-2-one 在 rhodium(II) acetate dimer 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 16.0h， 生成
  参考文献：
  名称：

  Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2

  摘要：

  A series of heterocycle-containing oxindoles was synthesized and their HIV antiviral activities were assessed. Some of these analogs exhibited potent inhibitory activities against both wild-type virus and a number of drug-resistant Mutant viruses. In addition, oxindole 9z also showed promising pharmacokinetics. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.01.066
• 作为产物：
  描述：

  喹啉-2-甲醛 、 5-氯靛红 在 哌啶 作用下， 以 乙醇 为溶剂， 生成 5-Chloro-3-[1-quinolin-2-yl-meth-(E)-ylidene]-1,3-dihydro-indol-2-one
  参考文献：
  名称：

  Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2

  摘要：

  A series of heterocycle-containing oxindoles was synthesized and their HIV antiviral activities were assessed. Some of these analogs exhibited potent inhibitory activities against both wild-type virus and a number of drug-resistant Mutant viruses. In addition, oxindole 9z also showed promising pharmacokinetics. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.01.066

文献信息

• USE OF NOVEL NEUROPROTECTIVE 3-SUBSTITUTED INDOLONE COMPOSITIONS
  申请人：D'Mello Santosh R.

  公开号：US20100298376A1

  公开（公告）日：2010-11-25

  The present invention provides compositions and methods of synthesizing optionally substituted 3-substituted indolin-2-ones and methods to employ the resultant compounds to protect against neurodegeneration including diseases such as Alzheimer's disease, Parkinson's disease, or Huntington's disease, and conditions such as ischemic stroke.